GOOGL
47
4
ORCL
33
7
CNX
49
3
AN
50
7
MS
74
5
BRK.B
33
-14
HPE
75
7
NOV
52
4
COP
47
3
LNC
75
2
AVY
47
-7
REGN
59
2
ISRG
71
4
CRM
70
18
SPG
48
2
WDC
70
2
HRL
23
-12
DHR
66
2
DTE
38
-4
ED
37
-6
GOOGL
47
4
ORCL
33
7
CNX
49
3
AN
50
7
MS
74
5
BRK.B
33
-14
HPE
75
7
NOV
52
4
COP
47
3
LNC
75
2
AVY
47
-7
REGN
59
2
ISRG
71
4
CRM
70
18
SPG
48
2
WDC
70
2
HRL
23
-12
DHR
66
2
DTE
38
-4
ED
37
-6
Financhill
Back

Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
78

GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF

Last Price:
$132.59
Seasonality Move:
3.87%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
78
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) is a Buy

Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?

  • The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $132.56. The Score for GSLC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • GSLC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GSLC Stock Price Chart

What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?

  • The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $132.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

GSLC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 55.09 Buy
Chaikin Money Flow: 136561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.1 - 133.06) Buy
Bollinger Bands (100): (126.51 - 131.89) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

GSLC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.26 Buy
20-day SMA: 131.82 Buy
50-day SMA: 130.89 Buy
200-day SMA: 121.79 Buy
8-day EMA: 132.01 Buy
20-day EMA: 131.74 Buy
50-day EMA: 128.69 Buy
200-day EMA: 82.51 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):